General Information of the Compound
Compound ID
CP0512693
Compound Name
2-propan-2-yl-3-[4-(trifluoromethoxy)phenyl]-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepine
    Show/Hide
Structure
Formula
C17H20F3N3O
Molecular Weight
339.361
Canonical SMILES
CC(C)n1nc2CCNCCc2c1-c1ccc(OC(F)(F)F)cc1
    Show/Hide
InChI
InChI=1S/C17H20F3N3O/c1-11(2)23-16(14-7-9-21-10-8-15(14)22-23)12-3-5-13(6-4-12)24-17(18,19)20/h3-6,11,21H,7-10H2,1-2H3
    Show/Hide
InChIKey
GGMVPOQERUVJGV-UHFFFAOYSA-N
Physicochemical Property
logP
3.7178
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
39.08
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 59752538
ChEMBL ID
CHEMBL4760784
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01746, 5-hydroxytryptamine receptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 5000 nM
   TI
   LI
   LO
   TS